"Long Shareholders are Family. I have a responsibility for

New Post Public Reply Private Reply Replies (0) Message Board
TraderJoe_80
653
"Long Shareholders are Family . I have a responsibility for their Wellbeing & Investment ." --> your CEO , Dr. David Dalton

1319217199_Wellbeingandinvestment.jpg

We have our own Telehealth platform - Wellness Teledoc
We have a new Gold Standard for pharmacists - Wellness RX
We have our own CARF Accredited Clinics - Time Enterrpise Organization
We have our own Pharmacy Benefits Management (PBM) - HRI $204 Million revs last year
We have our own company in Israel and EU - Euromed and their sub Eurocann Agritech
We have partnerships with several huge companies - Rite Aid, TLRY, HRVSF, ISCNF + MANY OTHERS both public and privately held. To be revealed.....
We control our own destiny!


DAVID L. DALTON is President and Chief Executive Officer of Univec, Inc. , which provides safety syringes and other safe healthcare products to caregivers and patients. Univec also provides pharmaceutical samples to physicians for pharmaceutical companies nationwide. Dr. Dalton has spent his professional career in the pharmaceutical industry, bringing over 30 years of experience to his profession. He received a BS in Pharmacy from West Virginia University in 1971 and was honored as one of the top 10 graduates over a 100-year span. Dr. Dalton became a Doctor of Pharmacy in 1974. He served in several capacities with Rite Aid Corporation from 1971 to 1989, including Corporate Vice President. He left Rite Aid Corporation to buy Peoples Drug Stores with an investment group inclusive of Robert Bass of Texas. Dr. Dalton served as Senior Vice President. Dr. Dalton then acquired Sherman Management Group and Medical Service Agency, where he served as Chairman, President, and CEO, which he merged in November 1994 to MEDNET, a public pharmacy benefit management company. Dr. Dalton served as Executive Vice President of MEDNET and President of Medi-Claim (a wholly owned subsidiary of MEDNET). Dr. Dalton's next venture, Managed Care Rx, a national specialty care pharmaceutical provider for assisted living facilities, nursing homes, and prisons, was merged with a subsidiary of Bergen Brunswick, a drug wholesale company with sales in excess of $14 billion. His current ventures, Health Resources, Inc., of which he is Founder, President and CEO is also a pharmacy benefit management company that has contracted with over 50,000 retail pharmacies for the fulfillment of prescription orders and Pharmacy Services, Inc., a national specialty Care pharmaceutical provider for nursing homes, assisted living, and correctional facilities. Dr. Dalton has served as a Board member on such organizations as Blue Shield of Pennsylvania, United Way, National Health Association, National Association of Chain Drug Stores, and is one of the original members and Directors of the National Council of Prescription Drug Programs which is the organization responsible for every prescription transaction technology platform in the United States.

Univec Conglomerate Inc (UNVC) Stock Research Links

UNVC Board Company Profile Buy Rating Time & Sales News Filings Financials
My mom says, "I'm the best stock trader she has ever seen and she's proud of me!"
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stage 2 Capital's $100M Venture Targets AI Growth

Updated Category News Views 25

Baby, when we talk venture capital these days, we're really talking about A, I, and some well-placed bets on the future. Stage 2 Capital just pulled together a hefty $100 million, ready to sink it into AI-powered B2B companies like there's no tomorrow. You can feel the gears shifting in the marketplace, and these folks are leading the charge with the new funds, Venture...

Continue Reading
Baijiu Shines at Melbourne Cup: A Cultural Exchange

Updated Category News Views 48

Baijiu Brews Cultural Ties at Melbourne Cup If you thought the Melbourne Cup was only about horse racing, think again. This year, the carnival wasn’t just a playground for the equestrian elite but also a stage for cultural exchange, and Chinese baijiu had its moment to shine. It’s not just about sipping a strong spirit; it's about bridging cultures and building...

Continue Reading
Rizzi Steps Down; Mogler Takes Helm at ALTOUR

Updated Category News Views 54

Changes in Leadership: The ALTOUR Shakeup You know, in the travel world, shifts in leadership can be quite the rollercoaster ride. We're talking about some pretty big shoes to fill over at ALTOUR, with Gabe Rizzi stepping back after a decade of driving the company's dynamic evolution. He’s not entirely out of the picture, though. Rizzi’s going to hang around as a...

Continue Reading
ACR Poker's $20M Series Sparks Player Excitement

Updated Category News Views 27

ACR Poker Lights Up the Felt Again Jump into the buzz, folks—ACR Poker's gone all-in with a whopping $20 million guaranteed Online Super Series (OSS). Now, they're no strangers to the high stakes and the whirlwind of adrenaline that comes with it. From November 8th to 24th, the action's hotter than the sun in Costa Rica, and every player wants a piece of the pie. Turbo...

Continue Reading
InMotion's 2026 Black Friday: Massive Hosting Discounts

Updated Category News Views 111

InMotion Hosting's Black Friday Bonanza You know the deal; when Black Friday rolls around, folks expect a blitz of sales, like a stampede through the digital aisles. This year, InMotion Hosting isn't just whispering in the wind—they're shouting with a hefty price slash across their offerings. I'm talking about up to 75% off on hosting and a 50% discount on managed...

Continue Reading
Kevlar® EXO™ Revolutionizes FIA Fuel Tank Standards

Updated Category News Views 237

A New Era in Motorsport Safety Arclin and Aero Tec Laboratories (ATL) are shaking up the motorsport world. Through their collaboration, they've achieved something that's been untouched for over 25 years—meeting the rigorous new FIA 8875-2025 standards. It's all thanks to Kevlar® EXO™, a cutting-edge material redefining what's possible in fuel tank safety. Breaking...

Continue Reading
HANGCHA's AI-Fork Revolution: Bold Steps to 2030

Updated Category News Views 55

Forklifts and the Future: A Fork in the Road for HANGCHA There's a movement happening, folks, and I don't mean in the usual stock ticker shift way. We're talking forklifts here—AI-powered, no less. HANGCHA Group, a name that may or may not roll off the tongue but sure makes waves in manufacturing, just held its 4th Global Dealers Conference in Hangzhou, China. If you're...

Continue Reading
Hitachi Vantara's Strategy for AI Data Infrastructure

Updated Category News Views 32

Building AI-Ready Infrastructure with Hitachi Vantara Here's the scoop, folks: Hitachi Vantara has tossed a new hat in the ring by boosting its Virtual Storage Platform One (VSP One) with fresh, AI-friendly capabilities. This isn't just some fiddle to stay in the tech race; they're laying down the tracks for how we park big AI in enterprise garages without blowing a fuse....

Continue Reading
UK's Gambling Fines Dwarf New Jersey: A Wake-Up Call

Updated Category News Views 56

Unpacking Britain's Tough Stance Flip on the news and you'll see chatter about UK gambling fines making American penalties look like pocket change. According to the latest Regulator Strictness Index 2026 from CasinoReviews.net, Britain has knocked American jurisdictions out of the park concerning fines related to failing vulnerable players. We're talking whopping...

Continue Reading
O-I Glass Faces Class Action: What Investors Must Know

Updated Category News Views 85

The Unsettling News for O-I Glass Investors Let me dive right into this mess about O-I Glass, Inc. (NYSE:OI). If you're tangled up in their stock, you probably felt that 15.01% nosedive in your portfolio recently. That's no minor blip. On July 28, 2026, as stocks were virtually put through the shredder, O-I Glass announced they had to cut down their financial guidance for...

Continue Reading

Top 5 Most Recently Viewed Articles

Sportradar's Strong Growth: First Quarter Financial Overview

Updated Category News Views 264

Sportradar's Performance in the First Quarter of 2025 Welcome to the exciting world of sports technology, where innovation meets thrill! Sportradar Group AG (NASDAQ: SRAD), a prominent global sports technology company, has recently shared its preliminary financial results for the first quarter ending March 31, 2025. With a commitment to enhancing the experiences of sports...

Continue Reading
System-on-Chip Market to Reach $205.97 Billion by 2029

Updated Category News Views 47

System-on-Chip Market Outlook The System-on-Chip (SoC) market is experiencing remarkable growth, driven by various factors that span several industries. With a current valuation of approximately USD 138.46 billion and expectations to surge to USD 205.97 billion by 2029, the trend represents a significant Compound Annual Growth Rate (CAGR) of about 8.3%. Key Drivers of...

Continue Reading
Why Investing in Pampa Energia (NYSE: PAM) Makes Sense Now

Updated Category News Views 206

Pampa Energia: A Prime Investment Opportunity Pampa Energia S.A. (NYSE: PAM) stands out in the energy sector, thanks to its strategic investments that enhance its asset quality and boost electricity generation capabilities. The company is focused on expanding its reach in electricity generation, transmission, and distribution, making it a compelling option for investors...

Continue Reading
XTI Aerospace Eyes Growth Amid Revenue Slip

Updated Category News Views 108

A Second Quarter Snapshot Ah, the world of aerospace—where soaring ambitions often face a reality check. XTI Aerospace, hitching a ride on the drone tech boom, found itself dealing with a mixed bag this past second quarter. Coming from the streets of Miami with its quarterly numbers, XTI's interim CEO Jeremy Schneiderman is banking on drones to lift their revenue skies....

Continue Reading
CARVYKTI® Shows Promising Long-Term Remission Rates in Myeloma

Updated Category News Views 256

Revolutionary Insights on CARVYKTI® for Myeloma Treatment Recent findings from the CARTITUDE-4 study shed light on the exciting potential of CARVYKTI® (ciltacabtagene autoleucel), offering new hope for patients battling relapsed or refractory multiple myeloma. The data indicate that a significant 80% of patients treated with this innovative therapy experienced no...

Continue Reading